Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Levodopa-Induced Dyskinesias in Parkinson’s Disease: An Overview on Pathophysiology, Clinical Manifestations, Therapy Management Strategies and Future Directions
Lazzaro di Biase, Pasquale Maria Pecoraro, Simona Paola Carbone, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4427-4427
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Motor network gamma oscillations in chronic home recordings predict dyskinesia in Parkinson’s disease
Maria Olaru, Stephanie Cernera, Amelia Hahn, et al.
Brain (2024) Vol. 147, Iss. 6, pp. 2038-2052
Closed Access | Times Cited: 17
Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson’s Disease
Érica Novaes Soares, Ana Carla dos Santos Costa, Gabriel de Jesus Ferrolho, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 474-474
Open Access | Times Cited: 10
The Roles of Neuroinflammation in l‐DOPA‐Induced Dyskinesia: Dissecting the Roles of NF‐κB and TNF‐α for Novel Pharmacological Therapeutic Approaches
Mohammad Yasin Zamanian, Maryam Golmohammadi, Zhanna R. Gardanova, et al.
European Journal of Neuroscience (2025) Vol. 61, Iss. 5
Open Access | Times Cited: 1
Machine learning and wearable sensors for automated Parkinson’s disease diagnosis aid: a systematic review
Lazzaro di Biase, Pasquale Maria Pecoraro, Giovanni Pecoraro, et al.
Journal of Neurology (2024) Vol. 271, Iss. 10, pp. 6452-6470
Closed Access | Times Cited: 7
Neuroactive steroids and Parkinson’s disease: Review of human and animal studies
Mélanie Bourque, Marc Morissette, Thérèse Di Paolo
Neuroscience & Biobehavioral Reviews (2023) Vol. 156, pp. 105479-105479
Closed Access | Times Cited: 14
Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson’s Disease
Érica Novaes Soares, Ana Carla dos Santos Costa, Gabriel de Jesus Ferrolho, et al.
(2024)
Open Access | Times Cited: 5
Assessing the Safety and Therapeutic Efficacy of Cannabidiol Lipid Nanoparticles in Alleviating Metabolic and Memory Impairments and Hippocampal Histopathological Changes in Diabetic Parkinson’s Rats
Sarawut Lapmanee, Sakkarin Bhubhanil, Prapimpun Wongchitrat, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 514-514
Open Access | Times Cited: 5
A decision support system based on recurrent neural networks to predict medication dosage for patients with Parkinson's disease
Atiye Riasi, Mehdi Delrobaei, Mehri Salari
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
An application of a disposable electrode for the sensitive, selective, and cost-effective voltammetric determination of antiparkinsonism drug entacapone based on both its oxidation and reduction
Kader Vural, Didem Giray Dilgin, Yusuf Dilgin
Journal of Solid State Electrochemistry (2025)
Closed Access
Levodopa treatment: impacts and mechanisms throughout Parkinson’s disease progression
Peter Riederer, Sabrina Strobel, Toshiharu Nagatsu, et al.
Journal of Neural Transmission (2025)
Open Access
Local Field Potentials and Neuron Activity in Motor Networks in Levodopa-Induced Dyskinesia in a Model of Parkinson’s Disease
E. S. Brazhnik, Ivan Mysin, Н Ю Новиков
Neuroscience and Behavioral Physiology (2025)
Closed Access
α-Synuclein Targeted Therapy with Multiple Pathological Improvement for Parkinson’s Disease by Macrocyclic Amphiphile Nanomedicine
Jian-Mei Gao, Wenbo Li, Yi Yang, et al.
Biomaterials (2025), pp. 123378-123378
Closed Access
Modulation of gut microbiota with probiotics as a strategy to counteract endogenous and exogenous neurotoxicity
Anatoly V. Skalny, Michael Aschner, В. А. Гриценко, et al.
Advances in neurotoxicology (2024), pp. 133-176
Open Access | Times Cited: 3
Drug repurposing for neurodegenerative diseases
Halak Shukla, D. James B. St. John, Shuvomoy Banerjee, et al.
Progress in molecular biology and translational science (2024), pp. 249-319
Closed Access | Times Cited: 2
Should continuous dopaminergic stimulation be a standard of care in advanced Parkinson’s disease?
Zvezdan Pirtošek, Valentina Leta, Peter Jenner, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 11, pp. 1395-1404
Closed Access | Times Cited: 4
Does Impaired Plantar Cutaneous Vibration Perception Contribute to Axial Motor Symptoms in Parkinson’s Disease? Effects of Medication and Subthalamic Nucleus Deep Brain Stimulation
Tobias Heß, Peter Themann, Christian Oehlwein, et al.
Brain Sciences (2023) Vol. 13, Iss. 12, pp. 1681-1681
Open Access | Times Cited: 4
Adipokines, Vitamin D, and Selected Inflammatory Biomarkers among Parkinson’s Disease Patients with and without Dyskinesia: A Preliminary Examination
Jan Milanowski, Jarosław Nuszkiewicz, Beata Lisewska, et al.
Metabolites (2024) Vol. 14, Iss. 2, pp. 106-106
Open Access | Times Cited: 1
Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson’s Disease
Érica Novaes Soares, Ana Carla dos Santos Costa, Gabriel de Jesus Ferrolho, et al.
(2024)
Open Access | Times Cited: 1
Extraction of malva sylvestris seed oil by soxhlet method and alginate/chitosan microencapsulation with a new method: Investigation of its cytotoxic effects on human neuroblastoma cell line (SH-SY5Y)
Hasan Ulusal, Fatma Ulusal, Ş. Burçak Dağli, et al.
Journal of Radiation Research and Applied Sciences (2024) Vol. 17, Iss. 2, pp. 100875-100875
Open Access | Times Cited: 1
Ethanolic Extract of <i>Alternanthera Sessilis</i>: A Potential Therapeutic Agent for Behavioral Improvements in Reserpine-Induced Parkinsonian Rats
Syed Liyakath Ali S, Prasanalakshmi Balaji, Aravind Kumar R, et al.
International Journal of Pharmaceutical Sciences and Drug Research (2024), pp. 251-259
Open Access | Times Cited: 1
Inhibition of neuroinflammation by GIBH-130 (AD-16) reduces neurodegeneration, motor deficits, and proinflammatory cytokines in a hemiparkinsonian model
M. Bianchetti, Ana Flávia Fernandes Ferreira, Luiz Roberto Britto
Frontiers in Neuroanatomy (2024) Vol. 18
Open Access | Times Cited: 1
Exceeding the Limits with Nutraceuticals: Looking Towards Parkinson’s Disease and Frailty
Martina Montanari, Nicola Biagio Mercuri, Giuseppina Martella
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 122-122
Open Access | Times Cited: 1
Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
Mélanie Bourque, Marc Morissette, Amandine Isenbrandt, et al.
Frontiers in Neuroendocrinology (2024), pp. 101156-101156
Open Access
Targeting serum response factor (SRF) deactivates ΔFosB and mitigates Levodopa-induced dyskinesia in a mouse model of Parkinson’s disease
Piniel Alphayo Kambey, Jiao Wu, Wenya Liu, et al.
Gene Therapy (2024) Vol. 31, Iss. 11-12, pp. 614-624
Closed Access
Local field potentials and neural activity in motor networks in levodopa-induced dykinesia in a model of Parkinson’s disease
E. S. Brazhnik, Ivan Mysin, Н Ю Новиков
Журнал высшей нервной деятельности им И П Павлова (2024) Vol. 74, Iss. 5, pp. 606-620
Closed Access
Page 1 - Next Page

Scroll to top